High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activitySohyon Lee, Berend Snijder, Bartłomiej Augustynek et al.|Nature Medicine|2024Cited by 68
Targeting tumour-intrinsic neural vulnerabilities of glioblastomaSohyon Lee, Berend Snijder, Tobias Weiß et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 3
Epigenetic modification and characterization of the MGMT promoter region using CRISPRoff in glioblastoma cellsRemi Weber, Flavio Vasella|Frontiers in Oncology|2024Cited by 3
Epigenetic modification and characterization of the <i>MGMT</i> promoter region using CRISPRoff in glioblastoma cellsRemi Weber, Flavio Vasella|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 0